Skip to main content

Table 3 Factors associated with cognitive impairment among COVID-19 survivors

From: Cognitive after-effects and associated correlates among post-illness COVID-19 survivors: a cross-sectional study, Egypt

Variable

Total MoCA score

t

P-value

≥ 26 (n = 41)

< 26 (n = 44)

Mean ± SD

Mean ± SD

Age

32.07 ± 8.11

39.57 ± 9.15

− 3.99

< 0.001

 

No

%

No

%

χ2

 

Gender

 Female

32

78.0

37

84.1

0.51

0.476

 Male

9

22.0

7

15.9

Marital status

 Married

34

82.9

41

93.2

2.15

0.143

 Not married

7

17.1

3

6.8

Residence

 Rural

23

56.1

32

72.7

2.57

0.109

 Urban

18

48.2

12

27.3

Level of education

 Low-to-moderate

17

41.5

36

81.8

14.72

< 0.001

 High

24

58.5

8

18.2

Occupation

 Skilled

39

95.1

38

86.4

2.20

0.334

 Employee

2

4.9

5

11.4

 Unemployed

0

0.0

1

2.3

Hx of psychiatric illnesses

 Yes

2

4.9

5

11.4

1.18

0.277

 No

39

95.1

39

88.6

Hx of medical illnesses

 Yes

8

19.5

11

25.0

0.37

0.544

 No

33

80.5

33

75.0

COVID-19 symptom severity

 Mild

21

51.2

19

43.2

0.55

0.458

 Moderate-to-severe

20

48.8

25

56.8

Medications received during COVID-19 infection

 Antibiotics

36

97.3

38

92.7

0.85

0.356

 Anticoagulants

22

59.5

27

65.9

0.34

0.560

 Antimalarial

17

45.9

20

48.8

0.06

0.802

 Iverizine

28

75.7

25

61.0

1.93

0.165

 Steroids

21

56.8

24

58.5

0.03

0.874

 

Mean ± SD

Mean ± SD

MWU

 

Home isolation (days)

9.80 ± 9.08

9.70 ± 10.20

− 0.38

0.418

Hospital isolation (days)

5.76 ± 8.71

7.20 ± 9.38

− 0.81

0.707

HADS scoring

 Depression

7.22 ± 4.56

9.02 ± 3.61

− 2.00

0.045

 Anxiety

7.34 ± 4.65

9.07 ± 3.61

− 1.80

0.072

  1. Bold text indicates statistical significance, where P value < 0.05